Dihexa Peptide is a synthetic small-molecule peptide-related compound derived from research surrounding hepatocyte growth factor (HGF) and the HGF/c-Met signaling pathway. It has attracted scientific interest because preclinical studies have investigated its effects on signaling associated with neuronal and synaptic biology.

Dihexa is particularly relevant to researchers studying neurobiology, cellular signaling, receptor pathways, synaptic function, and structure–activity relationships.

It is important to distinguish research findings from established clinical applications. Dihexa remains a research compound and should not be marketed as an approved treatment for neurological or cognitive conditions.

Research Use Only: Dihexa Peptide is supplied for laboratory and scientific research purposes only. It is not intended for human or veterinary use, diagnosis, treatment, cure, or prevention of disease.

1. What Is Dihexa Peptide?

Dihexa is a synthetic compound developed from research into angiotensin IV-related analogues and their interaction with the HGF/c-Met signaling system.

Unlike many conventional peptides, Dihexa is a relatively small heptapeptide-derived compound with chemical modifications that influence its biological and pharmacological properties.

Researchers have investigated Dihexa in experimental models involving:

• Neurobiology
• Synaptic signaling
• Cellular communication
• HGF/c-Met pathway research
• Structure–activity relationship studies
• Peptide-derived compound research
• Experimental learning and memory models

Much of the interest surrounding Dihexa comes from preclinical research. Experimental findings in cell and animal models should not be interpreted as proof of safety or efficacy in humans.

2. Molecular Formula, Molecular Weight & Sequence

Commonly reported information for Dihexa includes:

Sequence / structural description

Dihexa is derived from the Angiotensin IV (Ang IV) sequence and incorporates chemical modifications designed to alter its properties.

It is commonly described structurally as:

N-hexanoyl-Tyr-Ile-(6-aminohexanoyl)-amide

Because Dihexa is a modified peptidomimetic rather than a conventional unmodified peptide, providing the exact chemical structure and molecular formula is more informative than representing it solely as a standard amino-acid sequence.

Important specification note

Chemical form matters. Researchers should verify the exact:

chemical structure → molecular formula → molecular weight → observed MS mass

against the batch-specific COA.

This is especially important for modified peptides and peptidomimetics because terminal groups and chemical modifications can significantly change molecular mass.

3. Purity

A suitable research-grade specification may be:

Purity: ≥98% by HPLC

The actual purity should always be confirmed using the batch-specific Certificate of Analysis (COA).

Depending on the analytical package, documentation may include:

• HPLC purity percentage
• HPLC chromatogram
• Mass spectrometry
• Calculated molecular weight
• Observed molecular weight
• Lot/batch number
• Testing date
• Net compound quantity

For research applications, a batch-specific COA provides substantially more useful information than a general purity statement alone.

4. Appearance

Appearance: White to off-white lyophilized powder.

The material may be supplied in a dry form suitable for controlled laboratory storage.

Minor variations in powder appearance can occur because of manufacturing and drying conditions.

However, visual appearance cannot establish identity or purity. Researchers should use appropriate analytical techniques such as HPLC and mass spectrometry when confirmation is required.

5. Available Vial Sizes

Dihexa Peptide can be offered in different research quantities depending on laboratory requirements.

Common research vial sizes include:

• 2 mg
• 5 mg
• 10 mg
• 20 mg
• 50 mg

For many laboratory projects, 5 mg and 10 mg formats are convenient research quantities.

Larger quantities may be suitable for laboratories performing repeated analytical or experimental work.

Always clearly state the net compound quantity per vial rather than confusing it with total vial or formulation weight.

6. Storage Recommendations

Proper storage helps maintain the integrity of research compounds.

For lyophilized Dihexa:

• Follow the storage conditions specified in the applicable product documentation.
• Keep the vial tightly sealed.
• Protect the material from moisture.
• Minimize exposure to excessive heat.
• Protect from unnecessary direct light.
• Avoid repeated temperature cycling.
• Allow a cold vial to equilibrate appropriately before opening to minimize condensation.

Controlled frozen storage may be appropriate for longer-term preservation when supported by relevant stability information.

Important: Storage requirements can depend on formulation, packaging, and stability data. Always prioritize the storage instructions supplied with the specific batch.

7. Reconstitution Information

Dihexa is supplied as a research material, and its preparation should be determined according to the laboratory’s validated experimental protocol.

Because Dihexa is a modified, relatively hydrophobic peptidomimetic, solubility can depend on solvent selection, concentration, pH, and experimental conditions.

General laboratory considerations include:

1. Allow the sealed vial to reach a suitable temperature before opening.
2. Select a solvent compatible with the experimental protocol.
3. Introduce the solvent carefully.
4. Avoid unnecessarily vigorous agitation.
5. Allow adequate time for dissolution.
6. Record the solvent and final concentration.
7. Consider aliquoting when appropriate to minimize repeated freeze–thaw exposure.
8. Store prepared material according to validated laboratory stability procedures.

There is no universal reconstitution volume or solvent that is appropriate for every Dihexa experiment.

Researchers should establish solubility and preparation conditions using their specific experimental requirements and applicable laboratory procedures.

8. Intended Use — Research Use Only

Dihexa Peptide is intended exclusively for laboratory research.

It should not be represented as:

• A cognitive-enhancement product
• A nootropic supplement
• A treatment for Alzheimer’s disease
• A treatment for dementia
• A treatment for neurological disorders
• An approved pharmaceutical
• A product for human self-administration

Dihexa research should remain within appropriate laboratory and institutional frameworks.

Research Use Only. Not for Human or Veterinary Use.

Researchers are responsible for complying with applicable regulations, institutional requirements, laboratory safety procedures, and appropriate waste-disposal practices.

9. Packaging & Shipping Information

Dihexa should be packaged appropriately to protect the research material during transportation.

Professional research packaging may include:

• Securely sealed vial
• Product identification label
• Net quantity
• Lot/batch number
• Research-use-only statement
• Protective secondary packaging
• Batch-specific COA or analytical documentation, where applicable

Upon delivery, researchers should inspect the package and vial for visible damage.

Before adding the product to laboratory inventory, verify:

Product name + quantity + lot number + chemical form + COA

Shipping conditions should follow the product’s applicable stability requirements and relevant transportation regulations.

10. Frequently Asked Questions About Dihexa Peptide

What is Dihexa Peptide?

Dihexa is a synthetic, modified peptide-derived compound associated with research into the HGF/c-Met signaling pathway and experimental neurobiology.

Is Dihexa a conventional peptide?

Dihexa is better described as a modified peptidomimetic compound rather than an unmodified naturally occurring peptide.

What is the molecular formula of Dihexa?

The commonly reported molecular formula is:

C₂₇H₄₄N₄O₅

What is the molecular weight of Dihexa?

The reported molecular weight is approximately:

504.67 g/mol

The exact observed mass should be confirmed against the product’s analytical documentation.

What is the CAS number?

Dihexa is commonly identified as CAS 1401708-83-5.

What is the chemical structure of Dihexa?

Dihexa is commonly described as:

N-hexanoyl-Tyr-Ile-(6-aminohexanoyl)-amide

It is derived from research into angiotensin IV-related structures.

What research areas involve Dihexa?

Research has investigated Dihexa in areas including neurobiology, synaptic signaling, HGF/c-Met pathways, cellular signaling, and experimental learning and memory models.

What purity should researchers look for?

A research-grade specification may state ≥98% purity by HPLC. Researchers should confirm the actual result using the COA for the specific batch.

What does Dihexa look like?

Research-grade Dihexa may be supplied as a white to off-white lyophilized powder.

Should Dihexa come with a COA?

For professional research supply, batch-specific analytical documentation is strongly preferable. Researchers should look for HPLC purity, mass spectrometry, molecular-weight information, lot number, and testing date where available.

How should Dihexa be stored?

Follow the storage instructions supplied with the specific batch. Protect the material from moisture, excessive heat, direct light, and unnecessary temperature cycling.

How is Dihexa reconstituted?

Preparation depends on the compound’s solubility characteristics and the laboratory’s experimental protocol. There is no universal reconstitution volume or solvent suitable for every research application.

Is Dihexa approved for human use?

A research-use-only Dihexa product should not be presented as an approved human therapeutic or cognitive-enhancement product.

Why is the COA important for Dihexa?

Because Dihexa is a chemically modified peptidomimetic, the COA helps researchers verify the identity, purity, molecular mass, and batch information of the material supplied.

11. Key Takeaway

Dihexa Peptide is a synthetic, modified peptide-derived compound associated with research into HGF/c-Met signaling and neurobiological pathways.

Commonly reported specifications include a molecular formula of C₂₇H₄₄N₄O₅ and molecular weight of approximately 504.67 g/mol.

Because Dihexa is a modified peptidomimetic, accurate chemical identification is especially important. Researchers should verify the:

• Chemical structure
• Molecular formula
• Molecular weight
• HPLC purity
• Mass-spectrometry result
• Lot number
• Batch-specific COA
• Storage requirements

A professional product page should emphasize transparent analytical information and research-use labeling rather than making unsupported claims about cognitive enhancement or medical benefits.

Research Use Only. Not for Human or Veterinary Use.

Continue Learning: If you found this guide helpful, you may also want to read our previous peptide education articles covering the following topics